Loss of Brain-enriched miR-124 MicroRNA Enhances Stem-like Traits and Invasiveness of Glioma Cells*

Background: miR-124 is a brain-enriched microRNA that has been shown to be down-regulated in glioma. Results: miR-124 inhibits glioma cell invasion and tumorigenicity and reduces neurosphere formation, CD133+ cell subpopulation, and stem cell marker expression in part by targeting SNAI2. Conclusion: Loss of miR-124 enhances the stem-like traits and invasiveness of glioma cells via SNAI2 signaling. Significance: Therapeutic strategies against glioma can be developed by restoring the level of miR-124. miR-124 is a brain-enriched microRNA that plays a crucial role in neural development and has been shown to be down-regulated in glioma and medulloblastoma, suggesting its possible involvement in brain tumor progression. Here, we show that miR-124 is down-regulated in a panel of different grades of glioma tissues and in all of the human glioma cell lines we examined. By integrated bioinformatics analysis and experimental confirmation, we identified SNAI2, which is often up-regulated in glioma, as a direct functional target of miR-124. Because SNAI2 has been shown to regulate stem cell functions, we examined the roles of miR-124 and SNAI2 in glioma cell stem-like traits. The results showed that overexpression of miR-124 and knockdown of SNAI2 reduced neurosphere formation, CD133+ cell subpopulation, and stem cell marker (BMI1, Nanog, and Nestin) expression, and these effects could be rescued by re-expression of SNAI2. Furthermore, enhanced miR-124 expression significantly inhibited glioma cell invasion in vitro. Finally, stable overexpression of miR-124 and knockdown of SNAI2 inhibited the tumorigenicity and invasion of glioma cells in vivo. These findings reveal, for the first time, that the tumor suppressor activity of miR-124 could be partly due to its inhibitory effects on glioma stem-like traits and invasiveness through SNAI2.

[1]  Zhigang Xie.  Brain Tumor Stem Cells , 2009, Neurochemical Research.

[2]  Jennifer W. J. Wong.  MicroRNA-Induced Silencing of Glioma Progression , 2010, The Journal of Neuroscience.

[3]  K. Wagner,et al.  Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  M. Rao,et al.  Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase , 2011, Cell.

[5]  R. Vibhakar,et al.  Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma , 2008, Journal of Neuro-Oncology.

[6]  Michael E. Berens,et al.  Molecular Mechanisms of Glioma Cell Migration and Invasion , 2004, Journal of Neuro-Oncology.

[7]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[8]  Ralph Weissleder,et al.  MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. , 2007, Cancer research.

[9]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[10]  Erika Pastrana,et al.  miR-124 regulates adult neurogenesis in the SVZ stem cell niche , 2009, Nature Neuroscience.

[11]  Suely K. N. Marie,et al.  Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR , 2008, Journal of Neuro-Oncology.

[12]  J. Hodgson,et al.  microRNAs in Gliomas: Small Regulators of a Big Problem , 2009, NeuroMolecular Medicine.

[13]  Jae W. Lee,et al.  The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. , 2007, Genes & development.

[14]  A. Hart,et al.  The pluripotency homeobox gene NANOG is expressed in human germ cell tumors , 2005, Cancer.

[15]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[16]  X. Bian,et al.  The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2 , 2011, Gut.

[17]  C. Dominici,et al.  Slug (SNAI2) Down-Regulation by RNA Interference Facilitates Apoptosis and Inhibits Invasive Growth in Neuroblastoma Preclinical Models , 2008, Clinical Cancer Research.

[18]  Claudia Petritsch,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .

[19]  M. Pérez-Caro,et al.  Function of the zinc-finger transcription factor SNAI2 in cancer and development. , 2007, Annual review of genetics.

[20]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[21]  H. Kung,et al.  microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs , 2009, Brain Research.

[22]  Kye-Seong Kim,et al.  miR‐124a Is Important for Migratory Cell Fate Transition During Gastrulation of Human Embryonic Stem Cells , 2010, Stem cells.

[23]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[24]  Xiangyin Kong,et al.  miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. , 2009, Human pathology.

[25]  Jana Novakova,et al.  MicroRNA involvement in glioblastoma pathogenesis. , 2009, Biochemical and biophysical research communications.

[26]  E. Chiocca,et al.  Emerging functions of microRNAs in glioblastoma , 2009, Journal of Neuro-Oncology.

[27]  G. Crabtree,et al.  MicroRNA-mediated switching of chromatin-remodelling complexes in neural development , 2009, Nature.

[28]  M. Berens,et al.  Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. , 2007, Journal of the National Cancer Institute.

[29]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Li Li,et al.  MicroRNA-mediated conversion of human fibroblasts to neurons , 2011, Nature.

[31]  Michael C. Ostrowski,et al.  MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. , 2010, Molecular cell.

[32]  H. Hoefler,et al.  Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. , 2009, Frontiers in bioscience.

[33]  S. Leung,et al.  Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma. , 2007, Journal of the National Cancer Institute.

[34]  O. Laerum,et al.  Invasiveness of human glioma cell lines in vitro: Relation to tumorigenicity in athymic mice , 2004, Acta Neuropathologica.

[35]  G. Bernier,et al.  BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal , 2009, The Journal of Neuroscience.

[36]  P. A. Pérez-Mancera,et al.  SLUG in cancer development , 2005, Oncogene.

[37]  G. Maira,et al.  Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications , 2007, Clinical Cancer Research.

[38]  H. Kung,et al.  MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. , 2009, Biochemical and biophysical research communications.

[39]  F. Gage,et al.  A functional study of miR-124 in the developing neural tube. , 2007, Genes & development.

[40]  M. Mareel,et al.  Clinical, cellular, and molecular aspects of cancer invasion. , 2003, Physiological reviews.

[41]  T. Wurdinger,et al.  MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators , 2008, Molecular and Cellular Biology.

[42]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[43]  Charles Duyckaerts,et al.  The 2007 WHO classification of tumors of the central nervous system – what has changed? , 2008, Current opinion in neurology.

[44]  W. Broaddus,et al.  Membrane-type Matrix Metalloproteinases (MT-MMP)s: Expression and Function During Glioma Invasion , 2001, Journal of Neuro-Oncology.

[45]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[46]  Guangjin Pan,et al.  Nanog and transcriptional networks in embryonic stem cell pluripotency , 2007, Cell Research.

[47]  Agnieszka Bronisz,et al.  Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.

[48]  Kai Stühler,et al.  Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas , 2010, Brain pathology.

[49]  T. Maniatis,et al.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. , 2007, Molecular cell.

[50]  Jean-Philippe Brunet,et al.  The melanocyte differentiation program predisposes to metastasis after neoplastic transformation , 2005, Nature Genetics.